Results 351 to 360 of about 448,615 (401)

TWEAK regulates the functions of hair follicle stem cells via the Fn14‐Wnt/β‐catenin‐CXCR4 signalling axis

Wound Repair and Regeneration, Volume 33, Issue 3, May/June 2025.
Abstract Hair follicle stem cells (HFSCs) are crucial for maintaining cutaneous functions under various pathological conditions, including wounds. Tumour necrosis factor‐like weak inducer of apoptosis (TWEAK) interacts with its receptor, fibroblast growth factor‐inducible 14 (Fn14), and plays a role in the development and tissue repair of skin diseases.
Xiaoyan Zou, Yaning Tian, Lingling Peng, Mai Luo, Zhu Yan, Zihan Xue, Xiaoming Liu, Yumin Xia   +7 more
wiley   +1 more source

Therapeutic Potential Effect of Glycogen Synthase Kinase 3 Beta (GSK-3β) Inhibitors in Parkinson Disease: Exploring an Overlooked Avenue. [PDF]

Mol Neurobiol
Turkistani A, Al-Kuraishy HM, Al-Gareeb AI, Albuhadily AK, Alexiou A, Papadakis M, Elfiky MM, Saad HM, Batiha GE.   +8 more
europepmc   +1 more source

Maternal Adiponectin Decreases Placenta Nutrient Transport in Mice

The FASEB Journal, Volume 39, Issue 8, 30 April 2025.
The schematic illustrates the impact of adiponectin in placental function and fetal growth in obese pregnant mice. Adiponectin influences the placenta, by phosphorylation of mTOR at Ser2448 which alters its activity. This results in reduced nutrient influx (red arrows) to the fetus, ultimately contributing to fetal growth restriction.
Manisha Samad, Benjamin Ulfenborg, Sahar Soleimani Sani, Marco Bauzá Thorbrügge, Man Mohan Shrestha, Claes Ohlsson, Manuel Maliqueo, Elisabet Stener‐Victorin, Ingrid Wernstedt Asterholm, Anna Benrick   +9 more
wiley   +1 more source

Multi-omics analysis of disulfidptosis regulators and therapeutic potential reveals glycogen synthase 1 as a disulfidptosis triggering target for triple-negative breast cancer. [PDF]

MedComm (2020)
Xie J, Deng X, Xie Y, Zhu H, Liu P, Deng W, Ning L, Tang Y, Sun Y, Tang H, Cai M, Xie X, Zou Y.   +12 more
europepmc   +1 more source

Expression of Concern "Glycogen synthase kinase-3β inhibition attenuates the development of bleomycin-induced lung injury". [PDF]

Int J Immunopathol Pharmacol
europepmc   +1 more source

Porphyromonas gingivalis LPS and Actinomyces naeslundii Conditioned Medium Enhance the Release of a Low Molecular Weight, Transcriptionally Active, Fragment of Glycogen Synthase-3 Kinase in IMR-32 Cell Line. [PDF]

J Alzheimers Dis Rep
Singhrao SK, Consoli C, Dennison SR, Kanagasingam S, Welbury R.   +4 more
europepmc   +1 more source

MiR-181c-5p Mitigates Tumorigenesis in Cervical Squamous Cell Carcinoma via Targeting Glycogen Synthase Kinase 3β Interaction Protein (GSKIP) [Retraction]. [PDF]

Onco Targets Ther
europepmc   +1 more source

Inhibition of glycogen synthase kinase-3 enhances NRF2 protein stability, nuclear localisation and target gene transcription in pancreatic beta cells. [PDF]

Redox Biol
Patibandla C, van Aalten L, Dinkova-Kostova AT, Honda T, Cuadrado A, Fernández-Ginés R, McNeilly AD, Hayes JD, Cantley J, Sutherland C.   +9 more
europepmc   +1 more source